Ultralow Prostate-Specific Antigen (PSA) Levels and Improved Oncological Outcomes in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Patients Treated with Apalutamide: A Real-World Multicentre Study. - López-Abad, Alicia; Belmonte, Mario; Ramírez Backhaus, Miguel; Server Gómez, Gerardo; Cao Avellaneda, Enrique; Moreno Alarcón, Cristóbal; López Cubillana, Pedro; Yago Giménez, Pablo; de Pablos Rodríguez, Pedro; Juan Fita, María José; Climent Durán, Miguel Ángel; Guardiola Ruiz, Iris; et al. (Journal of Clinical Medicine, 2024)